🇺🇸 FDA
Patent

US 8119634

Dual-acting pyrazole antihypertensive agents

granted A61PA61P13/00A61P13/12

Quick answer

US patent 8119634 (Dual-acting pyrazole antihypertensive agents) held by Theravance, Inc. expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P13/00, A61P13/12, A61P29/00, A61P3/06